Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 19 June 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Latest impact factors for gastroenterology and hepatology journals

Interesting changes have been revealed from the latest gastroenterology and hepatology journal impact factors, for the year 2000.

News image

fiogf49gjkf04

Gastroenterology is still the journal with the greatest impact factor, followed by Hepatology.

However, now in third place is Seminars in Liver Disease. This journal was 7th in 1999. Gut has therefore been displaced into 4th place.

Alimentary Pharmacology & Therapeutics is another improver - it has moved up to 6th place, from last year's position of 8th.

The impact factors are published by ISI. Their definition of an impact factor is "a measure of the frequency with which the 'average article' in a journal has been cited in a particular year or period."

The annual journal citation report impact factor is a ratio between citations and recent citable items published. Thus, the impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.

Journals with greatest impact:
1 Gastroenterology
2 Hepatology
3 Semin Liver Dis
4 Gut
5 J Hepatol
6 Aliment Pharmacol Ther
ISI

ISI explain that, "The impact factor is useful in clarifying the significance of absolute (or total) citation frequencies. It eliminates some of the bias of such counts, which favor large journals over small ones, or frequently issued journals over less frequently issued ones, and of older journals over newer ones. Particularly in the latter case such journals have a larger citable body of literature than smaller or younger journals.

"All things being equal, the larger the number of previously published articles, the more often a journal will be cited."

Here is the "Top Forty Four" of the impact factors for 2000:

Journal    Impact factor
Gastroenterology    12.246
Hepatology    7.304
Semin Liver Dis    6.012
Gut    5.386
J Hepatol    3.761
Aliment Pharmacol Ther    3.489
Am J Physiol-Gastr L    3.115
Am J Gastroenterol    2.834
Gastrointest Endosc    2.820
Helicobacter    2.639
J Viral Hepat    2.157
Liver Transplant    2.130
Neurogastroenterol Motil    2.081
Scand J Gastroenterol    1.842
Endoscopy    1.817
Hepatol Res    1.808
Inflamm Bowel Dis    1.791
Digestion    1.780
Gastroenterol Clin North Am    1.774
Liver    1.739
Bailliere Clin Gastr    1.733
Int J Colorectal Dis    1.707
Dis Colon Rectum    1.690
Can J Gastroenterol    1.645
J Pediatr Gastroenterol Nutr    1.580
Dig Dis Sci    1.498
Ital J Gastroenterol    1.289
Eur J Gastroenterol Hepatol    1.142
J Clin Gastroenterol    1.127
J Gastroenterol Hepatol    1.116
World J Gastroenterol    0.993
J Gastroenterol    0.990
Gastroen Clin Biol    0.927
Hepato-Gastroenterol    0.905
Z Gatsroenterol    0.887
Abdom Imaging    0.886
Dig Surg    0.810
Dig Dis    0.744
Acta Gastro-Ent Belg    0.605
Curr Opin Gastroen    0.577
Rev Esp Enferm Dig    0.384
J Diarrhoel Dis Res    0.379
Chir Gastroenterol    0.078
Best Pract Res Cl Ga    0.067

ISI
03 September 2001

Go to top of page Email this page Email this page to a colleague

 31 May 2018 
Diagnostic for NAFLD  
 31 May 2018 
Bile acids and the risks for hepatotoxicity
 31 May 2018 
Rectal cancer female sexuality score
 30 May 2018 
Fungal dysbiosis in cirrhosis
 30 May 2018 
Placebo rates in ulcerative colitis trials
 30 May 2018 
Follow-up testing and colorectal cancer mortality
 29 May 2018 
Organ transplantation donors
 29 May 2018 
Novel therapies for IBD
 29 May 2018 
Helicobacter pylori infection to stomach cancer
 28 May 2018 
Mesalazine in ulcerative colitis
 28 May 2018 
Technology and management of digestive diseases
 28 May 2018 
Therapeutic strategies for HCV
 25 May 2018 
Post‐operative complications in elderly IBD
 25 May 2018 
Technology to increase colorectal cancer screening
 25 May 2018 
Colorectal cancer–specific mortality
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Precision medicine for tumors
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
New therapies for CDI
 15 May 2018 
Hep B in the Grey Zone
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Chronic Hep B
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Symptom assessment in cirrhotic ascites
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
European guidelines on pancreatic cystic neoplasms

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us